Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction

Ke Cheng, Tao Sheng Li, Konstantinos Malliaras, Darryl R. Davis, Yiqiang Zhang, Eduardo Marbán

Research output: Contribution to journalArticle

Abstract

RATIONALE: The success of cardiac stem cell therapies is limited by low cell retention, due at least in part to washout via coronary veins. OBJECTIVE: We sought to counter the efflux of transplanted cells by rendering them magnetically responsive and imposing an external magnetic field on the heart during and immediately after injection. METHODS AND RESULTS: Cardiosphere-derived cells (CDCs) were labeled with superparamagnetic microspheres (SPMs). In vitro studies revealed that cell viability and function were minimally affected by SPM labeling. SPM-labeled rat CDCs were injected intramyocardially, with and without a superimposed magnet. With magnetic targeting, cells were visibly attracted toward the magnet and accumulated around the ischemic zone. In contrast, the majority of nontargeted cells washed out immediately after injection. Fluorescence imaging revealed more retention of transplanted cells in the heart, and less migration into other organs, in the magnetically targeted group. Quantitative PCR confirmed that magnetic targeting enhanced cell retention (at 24 hours) and engraftment (at 3 weeks) in the recipient hearts by ≈3-fold compared to nontargeted cells. Morphometric analysis revealed maximal attenuation of left ventricular remodeling, and echocardiography showed the greatest functional improvement, in the magnetic targeting group. Histologically, more engrafted cells were evident with magnetic targeting, but there was no incremental inflammation. CONCLUSIONS: Magnetic targeting enhances cell retention, engraftment and functional benefit. This novel method to improve cell therapy outcomes offers the potential for rapid translation into clinical applications.

Original languageEnglish (US)
Pages (from-to)1570-1581
Number of pages12
JournalCirculation Research
Volume106
Issue number10
DOIs
StatePublished - May 28 2010
Externally publishedYes

Fingerprint

Iron
Myocardial Infarction
Microspheres
Magnets
Cell- and Tissue-Based Therapy
Injections
Ventricular Remodeling
Optical Imaging
Magnetic Fields
Echocardiography
Cell Survival
Coronary Vessels
Stem Cells
Inflammation
Polymerase Chain Reaction

Keywords

  • Cardiac progenitor cells
  • Cell transplantation
  • Myocardial infarction
  • Targeted cell delivery

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. / Cheng, Ke; Li, Tao Sheng; Malliaras, Konstantinos; Davis, Darryl R.; Zhang, Yiqiang; Marbán, Eduardo.

In: Circulation Research, Vol. 106, No. 10, 28.05.2010, p. 1570-1581.

Research output: Contribution to journalArticle

Cheng, Ke ; Li, Tao Sheng ; Malliaras, Konstantinos ; Davis, Darryl R. ; Zhang, Yiqiang ; Marbán, Eduardo. / Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. In: Circulation Research. 2010 ; Vol. 106, No. 10. pp. 1570-1581.
@article{02c67237324149a6b49ace46459ac415,
title = "Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction",
abstract = "RATIONALE: The success of cardiac stem cell therapies is limited by low cell retention, due at least in part to washout via coronary veins. OBJECTIVE: We sought to counter the efflux of transplanted cells by rendering them magnetically responsive and imposing an external magnetic field on the heart during and immediately after injection. METHODS AND RESULTS: Cardiosphere-derived cells (CDCs) were labeled with superparamagnetic microspheres (SPMs). In vitro studies revealed that cell viability and function were minimally affected by SPM labeling. SPM-labeled rat CDCs were injected intramyocardially, with and without a superimposed magnet. With magnetic targeting, cells were visibly attracted toward the magnet and accumulated around the ischemic zone. In contrast, the majority of nontargeted cells washed out immediately after injection. Fluorescence imaging revealed more retention of transplanted cells in the heart, and less migration into other organs, in the magnetically targeted group. Quantitative PCR confirmed that magnetic targeting enhanced cell retention (at 24 hours) and engraftment (at 3 weeks) in the recipient hearts by ≈3-fold compared to nontargeted cells. Morphometric analysis revealed maximal attenuation of left ventricular remodeling, and echocardiography showed the greatest functional improvement, in the magnetic targeting group. Histologically, more engrafted cells were evident with magnetic targeting, but there was no incremental inflammation. CONCLUSIONS: Magnetic targeting enhances cell retention, engraftment and functional benefit. This novel method to improve cell therapy outcomes offers the potential for rapid translation into clinical applications.",
keywords = "Cardiac progenitor cells, Cell transplantation, Myocardial infarction, Targeted cell delivery",
author = "Ke Cheng and Li, {Tao Sheng} and Konstantinos Malliaras and Davis, {Darryl R.} and Yiqiang Zhang and Eduardo Marb{\'a}n",
year = "2010",
month = "5",
day = "28",
doi = "10.1161/CIRCRESAHA.109.212589",
language = "English (US)",
volume = "106",
pages = "1570--1581",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction

AU - Cheng, Ke

AU - Li, Tao Sheng

AU - Malliaras, Konstantinos

AU - Davis, Darryl R.

AU - Zhang, Yiqiang

AU - Marbán, Eduardo

PY - 2010/5/28

Y1 - 2010/5/28

N2 - RATIONALE: The success of cardiac stem cell therapies is limited by low cell retention, due at least in part to washout via coronary veins. OBJECTIVE: We sought to counter the efflux of transplanted cells by rendering them magnetically responsive and imposing an external magnetic field on the heart during and immediately after injection. METHODS AND RESULTS: Cardiosphere-derived cells (CDCs) were labeled with superparamagnetic microspheres (SPMs). In vitro studies revealed that cell viability and function were minimally affected by SPM labeling. SPM-labeled rat CDCs were injected intramyocardially, with and without a superimposed magnet. With magnetic targeting, cells were visibly attracted toward the magnet and accumulated around the ischemic zone. In contrast, the majority of nontargeted cells washed out immediately after injection. Fluorescence imaging revealed more retention of transplanted cells in the heart, and less migration into other organs, in the magnetically targeted group. Quantitative PCR confirmed that magnetic targeting enhanced cell retention (at 24 hours) and engraftment (at 3 weeks) in the recipient hearts by ≈3-fold compared to nontargeted cells. Morphometric analysis revealed maximal attenuation of left ventricular remodeling, and echocardiography showed the greatest functional improvement, in the magnetic targeting group. Histologically, more engrafted cells were evident with magnetic targeting, but there was no incremental inflammation. CONCLUSIONS: Magnetic targeting enhances cell retention, engraftment and functional benefit. This novel method to improve cell therapy outcomes offers the potential for rapid translation into clinical applications.

AB - RATIONALE: The success of cardiac stem cell therapies is limited by low cell retention, due at least in part to washout via coronary veins. OBJECTIVE: We sought to counter the efflux of transplanted cells by rendering them magnetically responsive and imposing an external magnetic field on the heart during and immediately after injection. METHODS AND RESULTS: Cardiosphere-derived cells (CDCs) were labeled with superparamagnetic microspheres (SPMs). In vitro studies revealed that cell viability and function were minimally affected by SPM labeling. SPM-labeled rat CDCs were injected intramyocardially, with and without a superimposed magnet. With magnetic targeting, cells were visibly attracted toward the magnet and accumulated around the ischemic zone. In contrast, the majority of nontargeted cells washed out immediately after injection. Fluorescence imaging revealed more retention of transplanted cells in the heart, and less migration into other organs, in the magnetically targeted group. Quantitative PCR confirmed that magnetic targeting enhanced cell retention (at 24 hours) and engraftment (at 3 weeks) in the recipient hearts by ≈3-fold compared to nontargeted cells. Morphometric analysis revealed maximal attenuation of left ventricular remodeling, and echocardiography showed the greatest functional improvement, in the magnetic targeting group. Histologically, more engrafted cells were evident with magnetic targeting, but there was no incremental inflammation. CONCLUSIONS: Magnetic targeting enhances cell retention, engraftment and functional benefit. This novel method to improve cell therapy outcomes offers the potential for rapid translation into clinical applications.

KW - Cardiac progenitor cells

KW - Cell transplantation

KW - Myocardial infarction

KW - Targeted cell delivery

UR - http://www.scopus.com/inward/record.url?scp=77953023119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953023119&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.109.212589

DO - 10.1161/CIRCRESAHA.109.212589

M3 - Article

VL - 106

SP - 1570

EP - 1581

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 10

ER -